Kenichiro Hasumi - Tokyo, JP Dean LeMar Mann - Rockville MD, US Kim Graulich Hankey - Edgewood MD, US Kristina Michelle Holt - Annapolis MD, US
Assignee:
Hasumi, LLC - New York NY University of Maryland, Baltimore - Baltimore MD
International Classification:
A61K 45/00 G01N 33/00
US Classification:
4242781, 435 724
Abstract:
The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.